-
EXCLUSIVE: Humacyte, Alpha Healthcare CEOs Talk SPAC Deal, Technology, Trials On 'SPACs Attack'
Tuesday, May 25, 2021 - 3:35pm | 558Read More...Humacyte is set to go public via the special purpose acquisition company Alpha Healthcare Acquisition Corp (NASDAQ: AHAC) in a deal that values the company at around $800 million. Humacyte founder and CEO Laura Niklason and Alpha Healthcare Acquisition CEO Rajiv...
